Projects per year
Previous research suggests uncertainty whether or not there is any additional benefit in adding antiplatelet therapy (APT) to anticoagulation therapy (ACT) in patients with high-risk atrial fibrillation (AF) in terms of reduction in vascular events, including stroke. The existing guidelines acknowledge an increased risk of bleeding associated with such a strategy; however, there is no consensus on the treatment pathway.
|Number of pages||188|
|Journal||Health Technology Assessment|
|Publication status||Published - Jul 2013|
FingerprintDive into the research topics of 'Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review'. Together they form a unique fingerprint.
- 1 Finished
Combined Anticoagulation and Antiplatelet Therapy for High-Risk Patients with Atrial Fibrillation: Systematic Review and Individual Patient Meta-Analysis
Lane, D., Fitzmaurice, D., Moore, D. & Lip, G.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/07/10 → 31/12/11
Project: Other Government Departments